Published in Clin Chim Acta on March 19, 1981
The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest (1966) 2.92
Threshold adrenocortical sensitivity in man and its possible application to corticotrophin bioassay. Lancet (1967) 2.44
Social and environmental factors and life expectancy, infant mortality, and maternal mortality rates: results of a cross-national comparison. Soc Sci Med (1994) 1.97
A detailed investigation of circulating IgE levels in a normal population. Clin Allergy (1975) 1.89
A rapid radioimmunoassay for human chorionic somatomammotrophin. J Obstet Gynaecol Br Commonw (1971) 1.54
A fundamental defect of adrenocortical control in Cushing's disease. J Endocrinol (1968) 1.46
Immunoreactive corticotrophin levels in adrenocortical insufficiency. Br Med J (1971) 1.46
Pituitary peptide. Nat New Biol (1973) 1.39
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood. J Endocrinol (1970) 1.35
Plasma-cortisol response to lysine-vasopressin. Comparison with other tests of human pituitary-adrenocortical function. Lancet (1965) 1.31
A rapid semi-automated method for the measurement of human chorionic somatomammotrophin. The normal range in the third trimester and its relation to fetal weight. J Obstet Gynaecol Br Commonw (1971) 1.30
Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins. J Clin Endocrinol Metab (1975) 1.30
Radioimmunoassay for determining plasms-levels of angiotensin II in man. Lancet (1967) 1.29
Polarisation fluoroimmunoassay of gentamicin. Clin Chim Acta (1976) 1.27
Influence of amphetamines on plasma corticosteroid and growth hormone levels in man. Br Med J (1969) 1.25
Placental lactogen levels as guide to outcome of threatened abortion. Br Med J (1972) 1.24
The physician-delivered smoking intervention project: can short-term interventions produce long-term effects for a general outpatient population? Health Psychol (1994) 1.24
C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta (1985) 1.22
Fluorometric assays for avidin and biotin. Methods Enzymol (1986) 1.22
Tumor and plasma ACTH concentrations in patients with and without the ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1972) 1.21
Plasma levels of immunoreactive corticotrophin in patients with Cushing's syndrome. Br Med J (1968) 1.14
Endocrine function in patients with untreated chromophobe adenomas. Q J Med (1967) 1.13
Antibodies to corticotrophin and their relation to adrenal function in children receiving corticotrophin therapy. Lancet (1967) 1.10
Linear regression analysis by Deming's method. Clin Chem (1980) 1.09
Plasma corticosteroid and growth hormone response to lysine-vasopressin in man. J Clin Endocrinol Metab (1968) 1.08
Circulating corticotrophin levels in severe hypopituitarism and in the neonate. Lancet (1973) 1.05
Adaptive e-learning to improve dietary behaviour: a systematic review and cost-effectiveness analysis. Health Technol Assess (2011) 1.04
Urinary thyroxine excretion as index of thyroid function. Lancet (1972) 1.03
Chemical characterization of ectopic ACTH purified from a malignant thymic carcinoid tumor. J Clin Endocrinol Metab (1976) 1.02
Growth hormone secretion in response to stress in man. Nature (1966) 0.99
Assessment of hypothalamic pituitary function in endocrine disease. J Clin Pathol (1966) 0.97
The development of a radioimmunoassay for arginine-vasopressin: production of antisera and labelled hormone; separation techniques; specificity and sensitivity of the assay in aqueous solution. J Endocrinol (1972) 0.96
Circulating levels of immunoglobulin E in patients with cancer. Lancet (1972) 0.95
The development of radioimmunoassays for fibrinogen degradation products: fragments D and E. Br J Haematol (1975) 0.94
Design of the immunogen and label for use in a fluoroimmunoassay for paracetamol. Ann Clin Biochem (1988) 0.94
Estimation of serum gentamicin by quenching fluoroimmunoassay. J Clin Pathol (1977) 0.94
Comparison of corticotrophin and corticosteroid response to lysine vasopressin, insulin, and pyrogen in man. Br Med J (1973) 0.94
Oral and intravenous suppression tests in the diagnosis of Cushing's syndrome. J Endocrinol (1965) 0.93
A review of fluoroimmunoassay and immunofluorometric assay. Ann Clin Biochem (1981) 0.92
INFORMAS and advocacy for public health nutrition and obesity prevention. Obes Rev (2013) 0.92
Effect of temperature on the radioiodination of human growth hormone. J Immunoassay (1981) 0.91
Patient delay and receipt of thrombolytic therapy among patients with acute myocardial infarction from a community-wide perspective. Am J Cardiol (1992) 0.91
Comparison of the redox assay for ACTH with previous assays. Nat New Biol (1973) 0.91
Thyroid function in the neonate. Clin Endocrinol (Oxf) (1973) 0.90
Corticotrophin-like peptides in the rat pituitary. J Endocrinol (1974) 0.88
Clinical biochemistry and endocrinology--the future. Ann Clin Biochem (1974) 0.88
Cortisol directly determined in serum by fluoroimmunoassay with magnetizable solid phase. Clin Chem (1980) 0.88
ACTH and MSH peptides in the human adult and fetal pituitary gland. Front Horm Res (1977) 0.87
A radioimmunoassay for retinol-binding protein in serum and urine. Clin Chem (1985) 0.87
Monitoring policy and actions on food environments: rationale and outline of the INFORMAS policy engagement and communication strategies. Obes Rev (2013) 0.86
Comparison of antibody production to human interleukin-6 (IL-6) by sheep and chickens. J Immunol Methods (1995) 0.86
A novel Fab-based antivenom for the treatment of mass bee attacks. Am J Trop Med Hyg (1999) 0.86
Urinary tri-iodothyronine excretion as index of thyroid function. Lancet (1972) 0.86
Immunoassays for low concentrations of albumin in urine. Clin Chem (1986) 0.86
A protocol for 'enhanced pepsin digestion': a step by step method for obtaining pure antibody fragments in high yield from serum. J Immunol Methods (2003) 0.86
Comparison of two triiodothyronine uptake techniques for the assessment of thyroid function. J Clin Pathol (1972) 0.86
Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies. Biochem J (1984) 0.85
Solid-phase fluoroimmunoassay of human albumin in biological fluids. Clin Chim Acta (1978) 0.85
The development of a radioimmunoassay for oxytocin: sensitivity of the assay in aqueous buffer solution, specificity and the dissociation of immunological and biological activity. J Endocrinol (1970) 0.84
Enhanced pepsin digestion: a novel process for purifying antibody F(ab')(2) fragments in high yield from serum. J Immunol Methods (2002) 0.84
Corticosteroid and growth-hormone response to synthetic lysine-vasopressin, natural vasopressin, saline solution, and venepuncture. Lancet (1968) 0.84
A simple competitive protein binding assay for plasma cortisol. Clin Chim Acta (1974) 0.84
Fluorimetric assays for avidin and biotin based on biotin-induced fluorescence enhancement of fluorescein-labeled avidin. Anal Biochem (1981) 0.84
A comparison of ovine and equine antivenoms. Toxicon (1994) 0.83
A rapid, simple assay for digoxin. J Clin Pathol (1974) 0.83
Patient characteristics and the effect of three physician-delivered smoking interventions. Prev Med (1992) 0.83
A simple solid-phase radioimmunoassay for triiodothyronine. Ann Clin Biochem (1975) 0.83
The measurement of urinary digoxin and dihydrodigoxin by radioimmunoassay and by mass spectroscopy. Clin Chim Acta (1975) 0.83
Antivenom: the most cost-effective treatment in the world? Toxicon (2010) 0.83
The radioimmunoassay of angiotensin II. Proc R Soc Lond B Biol Sci (1969) 0.83
Clinical and biochemical studies of a patient with a corticosterone-secreting adrenocortical tumour. Lancet (1968) 0.82
Proceedings: Urinary free cortisol excretion by normal subjects. J Endocrinol (1974) 0.82
Polarisation fluoroimmunoassay of phenytoin. Clin Chim Acta (1978) 0.82
Novel 125I-labeled nortriptyline derivatives and their use in liquid-phase or magnetizable solid-phase second-antibody radioimmunoassays. Clin Chem (1979) 0.82
Direct determination of phenobarbital in serum or plasma by polarization fluoroimmunoassay. Ther Drug Monit (1982) 0.81
Effects of oestrogen on urinary thyrosine excretion. Br Med J (1972) 0.81
An affinity purified ovine antivenom for the treatment of Vipera berus envenoming. Toxicon (1992) 0.81
Emergency chemical pathology service in central London. Lancet (1971) 0.80
Tumour-associated hormonal products. J Clin Pathol Suppl (R Coll Pathol) (1974) 0.80
Production of polyclonal antibodies in ascitic fluid of mice: technique and applications. J Immunoassay (1988) 0.80
Production and assessment of ovine antisera for the manufacture of a veterinary adder antivenom. Vet Rec (2014) 0.80
A new antivenom to treat eastern coral snake (Micrurus fulvius fulvius) envenoming. Toxicon (1994) 0.80
Stability of thyroxine and triiodothyronine in biological fluids. J Clin Pathol (1975) 0.80
Experimental assessment of a new, low-cost antivenom for treatment of carpet viper (Echis ocellatus) envenoming. Toxicon (1995) 0.79
Indirect quenching fluoroimmunoassay. Methods Enzymol (1981) 0.79
The effect of fluorescein labels on the affinity of antisera to small haptens. J Immunol Methods (1991) 0.79
Introduction of a rapid, simple radioimmunoassay and quality control scheme for thyroxine. J Clin Pathol (1976) 0.79
Factors associated with heavy smoking among men and women: the physician-delivered smoking intervention project. Am Heart J (1993) 0.79
Dual-label fluoroimmunoassay for simultaneous determination of primidone and phenobarbital. Ther Drug Monit (1985) 0.78
Non-separation fluoroimmunoassay of human albumin in biological fluids. Clin Chim Acta (1978) 0.78
Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction. Gut (1998) 0.78
The development of a radioimmunoassay for oxytocin: radioiodination, antibody production and separation techniques. J Endocrinol (1970) 0.78
Radioimmunoassay and saturation analysis. Immunoassay in the diagnostic laboratory. Br Med Bull (1974) 0.78